RFK Jr. and the Future of Pharma

This chapter examines the potential impact of Robert F. Kennedy Jr.'s confirmation on the pharmaceutical and food industries, with a focus on lobbying efforts and transparency in drug policies. It also discusses recent earnings from Pfizer and underscores the need for balance in drug access and innovation amidst evolving healthcare policies.

Transcript

Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!

Get the app